Skin necrosis revealing antiphospholipid syndrome during immunotherapy for melanoma

Acta Derm Venereol. 2010 Jul;90(4):433-4. doi: 10.2340/00015555-0877.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Anticoagulants / therapeutic use
  • Antineoplastic Agents / adverse effects
  • Antiphospholipid Syndrome / drug therapy
  • Antiphospholipid Syndrome / immunology*
  • Antiphospholipid Syndrome / pathology
  • Biopsy
  • Calcium Channel Blockers / therapeutic use
  • Dendritic Cells / immunology
  • Dendritic Cells / transplantation
  • Drug Therapy, Combination
  • Hand
  • Humans
  • Immunotherapy / adverse effects*
  • Interferon alpha-2
  • Interferon-alpha / adverse effects
  • Lymphatic Metastasis
  • Male
  • Melanoma / immunology
  • Melanoma / secondary
  • Melanoma / therapy*
  • Middle Aged
  • Necrosis
  • Polyethylene Glycols / adverse effects
  • Recombinant Proteins
  • Skin / immunology*
  • Skin / pathology
  • Toes
  • Treatment Outcome

Substances

  • Anticoagulants
  • Antineoplastic Agents
  • Calcium Channel Blockers
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Polyethylene Glycols
  • peginterferon alfa-2b